Fingerprint
Dive into the research topics of 'Phase I study of rubitecan and gemcitabine in patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
P. M. Fracasso, J. S. Rader, R. Govindan, T. J. Herzog, M. A. Arquette, A. Denes, D. G. Mutch, J. Picus, B. R. Tan, C. L. Fears, S. A. Goodner, S. L. Sun
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Medical Oncology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Division of Gynecologic Oncology
- Division of Oncology
- Rheumatic Diseases Research Resource-Based Center
- Mentorship to Enhance Diversity in Academia (MEDA)
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations